Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathy

Basic Research in Cardiology

Volumn 110, Issue 6, 2015, Pages

  Haghikia, Arash ^a   Kaya, Ziya ^b   Schwab, Johannes ^c   Westenfeld, Ralf ^d   Ehlermann, Philipp ^b   Bachelier, Katrin ^e   Oettl, Renate ^b   von Kaisenberg, Constantin S ^a   Katus, Hugo A ^b   Bauersachs, Johann ^a   Hilfiker Kleiner, Denise ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Paracelsus Medical University   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

Author keywords

Autoantibodies; Biomarker; Peripartum cardiomyopathy

Indexed keywords

AUTOANTIBODY; CARDIAC MYOSIN; TROPONIN I; MYOSIN HEAVY CHAIN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; PERICARDIAL EFFUSION; PERIPARTUM CARDIOMYOPATHY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; BLOOD; CARDIOMYOPATHY; IMMUNOLOGY; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY;

ADULT; AUTOANTIBODIES; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MYOSIN HEAVY CHAINS; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDIES; TROPONIN I;

EID: 84945544503     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-015-0517-2     Document Type: Article

References (43)

1. Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB (2002) Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 23:301–324. doi:10.1385/CRIAI:23:3:301
2. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S (1992) Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85:1734–1742. doi:10.1161/01.CIR.85.5.1734
3. Cenac A, Gaultier Y, Devillechabrolle A, Moulias R (1988) Enterovirus infection in peripartum cardiomyopathy. Lancet 2:968–969. doi:10.1016/S0140-6736(88)92641-4
4. Cooper LT, Belohlavek M, Korinek J, Yoshifuku S, Sengupta PP, Burgstaler EA, Winters JL (2007) A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy. J Clin Apher 22:210–214. doi:10.1002/jca.20130
5. Doesch AO, Mueller S, Nelles M, Konstandin M, Celik S, Frankenstein L, Goeser S, Kaya Z, Koch A, Zugck C, Katus HA (2011) Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy. Basic Res Cardiol 106:25–35. doi:10.1007/s00395-010-0126-z
6. Farley DM, Grainger DA, Tjaden BL, Frazier LM, Maki JE (2007) Use of a gestational carrier for a patient with recurrent adverse pregnancy outcomes from early onset severe pre-eclampsia. Fertil Steril 87:189. doi:10.1016/j.fertnstert.2006.04.050
7. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084. doi:10.1056/NEJM200004133421502
8. Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, Becker A, Yip A, Klein G, Sliwa K (2008) Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail 10:861–868. doi:10.1016/j.ejheart.2008.07.005
9. Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS, Illum S, Hatamizadeh P, Elkayam U (2009) Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 15:645–650. doi:10.1016/j.cardfail.2009.03.008
10. Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Froland SS, Aukrust P (2001) Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 103:220–225. doi:10.1161/01.CIR.103.2.220
11. Gleicher N, Elkayam U (2009) Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev 8:384–387. doi:10.1016/j.autrev.2008.12.003
12. Gleicher N (2008) Graft-versus-host disease and immunologic rejection: implications for diagnosis and treatments of pregnancy complications. Expert Rev Obstet Gynecol 3:37–49. doi:10.1586/17474108.3.1.37
13. Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, Tsikas D, Jordan J, Lichtinghagen R, von Kaisenberg CS, Struman I, Bovy N, Sliwa K, Bauersachs J, Hilfiker-Kleiner D (2013) Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 108:366. doi:10.1007/s00395-013-0366-9
14. Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen NQ, Scherr M, Castermans K, Malvaux L, Lambert V, Thiry M, Sliwa K, Noel A, Martial JA, Hilfiker-Kleiner D, Struman I (2013) MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 123:2143–2154. doi:10.1172/JCI64365
15. Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 16:619–628. doi:10.1056/NEJMoa1110186
16. Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J (2015) Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 36:1090–1097. doi:10.1093/eurheartj/ehv009
17. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H (2007) A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589–600. doi:10.1016/j.cell.2006.12.036
18. Hilfiker-Kleiner D, Sliwa K (2014) Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol 11:364–370. doi:10.1038/nrcardio
19. Ikeda U, Kasai H, Izawa A, Koyama J, Yazaki Y, Takahashi M, Higuchi M, Koh CS, Yamamoto K (2008) Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure. Curr Cardiol Rev 4:219–222. doi:10.2174/157340308785160534
20. Kaya Z, Leib C, Katus HA (2012) Autoantibodies in heart failure and cardiac dysfunction. Circ Res 110:145–158. doi:10.1161/CIRCRESAHA.111.243360
21. Knebel F, Bohm M, Staudt A, Borges AC, Tepper M, Jochmann N, Wernicke KD, Felix S, Baumann G (2004) Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy. Int J Cardiol 97:517–520. doi:10.1016/j.ijcard.2003.12.003
22. Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, Jain D, Gass A, Ahmed A, Panza JA, Fonarow GC (2014) Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc 3:e001056. doi:10.1161/CIRCULATIONAHA.114.014542
23. Lamparter S, Pankuweit S, Maisch B (2007) Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol 118:14–20. doi:10.1016/j.ijcard.2006.04.090
24. Leuschner F, Li J, Göser S, Reinhardt L, Ottl R, Bride P, Zehelein J, Pfitzer G, Remppis A, Giannitsis E, Katus HA, Kaya Z (2008) Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J 29:1949–1955. doi:10.1093/eurheartj/ehn268
25. Li Y, Heuser JS, Cunningham LC, Kosanke SD, Cunningham MW (2006) Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 177:8234–8240. doi:10.4049/jimmunol.177.11.8234
26. Liu J, Wang Y, Chen M, Zhao W, Wang X, Wang H, Zhang Z, Zhang J, Xu L, Chen J, Yang X, Zhang L (2014) The correlation between peripartum cardiomyopathy and autoantibodies against cardiovascular receptors. PLoS One 9:e86770. doi:10.1371/journal.pone.0086770
27. Lv H, Havari E, Pinto S, Gottumukkala RV, Cornivelli L, Raddassi K, Matsui T, Rosenzweig A, Bronson RT, Smith R, Fletcher AL, Turley SJ, Wucherpfennig K, Kyewski B, Lipes MA (2011) Impaired thymic tolerance to alpha-myosin directs autoimmunity to the heart in mice and humans. J Clin Invest 121:1561–1573. doi:10.1172/JCI44583
28. Melvin KR, Richardson PJ, Olsen EG, Daly K, Jackson G (1982) Peripartum cardiomyopathy due to myocarditis. N Engl J Med 307:731–734. doi:10.1056/NEJM198209163071207
29. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869. doi:10.1093/eurjhf/hfs105
30. McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, Modi K, Alexis JD, Ramani GV, Semigran MJ, Haythe J, Markham DW, Marek J, Gorcsan J 3rd, Wu WC, Lin Y, Halder I, Pisarcik J, Cooper LT, Fett JD, Investigators IPAC (2015) Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 66:905–914. doi:10.1016/j.jacc.2015.06.1309
31. Nussinovitch U, Shoenfeld Y (2013) The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease. Clin Rev Allergy Immunol 44:98–108. doi:10.1007/s12016-010-8229-8
32. Parks SB, Kushner JD, Nauman D, Burgess D, Ludwigsen S, Peterson A, Li D, Jakobs P, Litt M, Porter CB, Rahko PS, Hershberger RE (2008) Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J 156:161–169. doi:10.1016/j.ahj.2008.01.026
33. Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, del Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z (2012) Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485:333–338. doi:10.1038/nature11040
34. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL (2000) Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283:1183–1188. doi:10.1001/jama.283.9.1183
35. Ricke-Hoch M, Bultmann I, Stapel B, Condorelli G, Rinas U, Sliwa K, Scherr M, Hilfiker-Kleiner D (2014) Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress. Cardiovasc Res 101:587–596. doi:10.1093/cvr/cvu010
36. Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME (1994) Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 74:474–477. doi:10.1016/0002-9149(94)90906-7
37. Sanderson JE, Olsen EG, Gatei D (1986) Peripartum heart disease: an endomyocardial biopsy study. Br Heart J 56:285–291. doi:10.1136/hrt.56.3.285
38. Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, McMurray J, Yamac H, Labidi S, Struman I, Hilfiker-Kleiner D (2010) Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121:1465–1473. doi:10.1161/CIRCULATIONAHA.109.901496
39. Sliwa K, Fett J, Elkayam U (2006) Peripartum cardiomyopathy. Lancet 368:687–693. doi:10.1016/S0140-6736(06)69253-2
40. Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, Ansari AA (2006) Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 27:441–446. doi:10.1093/eurheartj/ehi481
41. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12:767–778. doi:10.1093/eurjhf/hfq120
42. Staudt A, Schaper F, Stangl V, Plagemann A, Bohm M, Merkel K, Wallukat G, Wernecke KD, Stangl K, Baumann G, Felix SB (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103:2681–2686. doi:10.1161/01.CIR.103.22.2681
43. van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, Hilfiker-Kleiner D, Bollen IA, Sliwa K, Alders M, Almomani R, van Langen IM, van der Meer P, Sinke RJ, van der Velden J, Van Veldhuisen DJ, van Tintelen JP, Jongbloed JD (2014) Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J 35:2165–2173. doi:10.1093/eurheartj/ehu050